Light therapy for fungal eye infection
Part of Eyes & vision clinical trials.
This study tests a new light-based treatment for a fungal eye infection called Fusarium keratitis. It aims to see if this therapy can help improve vision and clear the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a fungal eye infection confirmed by a lab test.
- You are over 18 years old.
- Your vision is between 20/40 and 20/400 in the affected eye.
- Your cornea (the clear front part of your eye) is thick enough, as measured by a special scan.
- You can understand the study and are willing to come back for follow-up visits.
- You do not have other eye infections, recent eye surgery, or a history of corneal transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial studies a light-guided eye treatment in people with generalized inherited retinal disease (a genetic cause of vision loss). It aims to see whether the approach works safely and can improve function for people whose vision is already significantly reduced.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This study tests an investigational new eye drop called IVIEW-1201 for treating fungal keratitis, a fungal infection of the cornea. It aims to see if it is safe and effective compared to standard treatment, which could help clear the infection and protect your vision.
This study tests whether a special low-level laser treatment (photobiomodulation) can help people with an early form of age-related macular degeneration called reticular pseudodrusen. It may slow vision loss or protect your eyes from getting worse.
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
Hear when a new Fusarium Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.